Kanaph Therapeutics
Company

Kanaph Therapeutics

Pharmaceutical Manufacturing Korea, Kr 16 employees
Employees
16
Contacts
1
Emails
1

Kanaph Therapeutics Overview

Headquarters
Korea, Kr
Industry
Pharmaceutical Manufacturing
Employees
16
Funding
17.8M
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Kanaph Therapeutics

Kanaph Therapeutics is a drug discovery and pre-clinical stage biotech based in Korea, with a large and small molecule two-track strategy for the development of first-in-class and best-in-class therapeutics in immuno-oncology, targeted therapy and autoimmune (ophthalmology) diseases. Our oncology pipeline includes bi-specific antibodies and small molecules that have a greatly enhanced immuno-stimulatory activity in the tumor micro-environment (TME) for efficient tumor eradication. Our autoimmune disease pipeline is composed of bispecific Fc-fusions that inhibit the alternative complement pathway while inhibiting angiogenesis and downstream complement activation as well.

Kanaph Therapeutics Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

Kanaph Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Hayoun (Helen) Jung Kanaph Therapeutics
View
Yeri Lee Kanaph Therapeutics Senior Scientist
Email
Young Soo Yoon Kanaph Therapeutics Managing Director
View
Dong Yoon Park Bioinformatics/data Analyst/biz
View

Employees by Management Level

Individual contributor 2 profiles
Director 1 profile
Senior / Lead 1 profile

Kanaph Therapeutics Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Kanaph Therapeutics